COVID-19: Enzyme targeted by virus also influences gut inflammation

An enzyme that helps COVID-19 (coronavirus) infect the body also plays a role in inflammation and patient outcomes in inflammatory bowel disease (IBD), according to a new study. The findings raise the possibility that anti-inflammatory drug therapies for IBD may aid recovery from coronavirus.